S164: DISEASE MODIFYING ACTIVITY OF IMETELSTAT IN PATIENTS WITH HEAVILY TRANSFUSED NON‐DEL(5Q) LOWER‐RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE…

Overview of attention for article published in HemaSphere, August 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 1 news story.

Uwe Platzbecker, MD Data from ongoing phase 3 clinical trials could continue to alter the treatment landscape for patients with…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.